Fernande Freyermuth

Fernande Freyermuth is a Principal Scientist and lab head at Sanofi, focusing on human diseases, particularly disorders involving RNA binding proteins, such as Amyotrophic Lateral Sclerosis and Myotonic Dystrophy. With a PhD in Molecular and Cellular Mechanisms in Human Disease from Université de Strasbourg, they have previously held roles as a Postdoctoral Researcher at Harvard Medical School and Massachusetts General Hospital, and at the University of California San Diego. Fernande has also worked as a Senior Scientist at Astellas Pharma US. Known for their motivation and organizational skills, they possess extensive expertise in molecular and cellular biology and the development of cellular models for neurological diseases.